Patent details

Basic Information

Publication number:

EP3033103

PCT Application Number:

US2014050122

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP148363922

PCT Publication Number:

WO2015023508

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

METHODS FOR IMPROVING ASTHMA SYMPTOMS USING BENRALIZUMAB

French Title of Invention:

PROCÉDÉS PERMETTANT D'AMÉLIORER LES SYMPTÔMES DE L'ASTHME AU MOYEN DE BENRALIZUMAB

German Title of Invention:

VERFAHREN ZUR VERBESSERUNG VON ASTHMASYMPTOMEN MIT BENRALIZUMAB

SPC Number:

Dates

Filing date:

07/08/2014

Grant date:

05/06/2019

EP Publication Date:

22/06/2016

PCT Publication Date:

19/02/2015

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

05/06/2019

EP B1 Publication Date:

05/06/2019

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

07/08/2019

Expiration date:

07/08/2034

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

29/05/2019

 

 

Name:

AstraZeneca AB

Address:

Forskargatan 18, 151 85 Södertälje, Sweden (SE)

Inventor

1

Name:

ROSKOS, Lorin

Address:

United States (US)

2

Name:

RAIBLE, Donald

Address:

United States (US)

3

Name:

WARD, Christine

Address:

United States (US)

4

Name:

WANG, Bing

Address:

United States (US)

Priority

Priority Number:

201361864950 P

Priority Date:

12/08/2013

Priority Country:

United States (US)

Classification

IPC classification:

A61K 39/00; A61K 39/395; G01N 33/48;

Publication

European Patent Bulletin

Issue number:

201923

Publication date:

05/06/2019

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages